Why is Remus Pharma. falling/rising?

As of 05-Sep, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 840.85, which reflects a decrease of Rs 42.15 or 4.77%. The stock has underperformed its sector by 4.7% today and is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, the stock is close to its 52-week low, being only 2.6% away from Rs 819. The recent delivery volume has also seen a significant drop, falling by 84.66% compared to the 5-day average, indicating a decrease in investor participation. Over the past week, the stock has declined by 5.73%, and year-to-date, it has dropped by 32.66%, while the one-year return shows a decrease of 35.07%. There are no positive factors available to counterbalance these negative trends.
Broader Market Context: In comparison to the benchmark Sensex, which has increased by 1.29% over the past week, Remus Pharmaceuticals Ltd's performance is notably poor. The Sensex has also shown a positive return of 4.64% year-to-date, while Remus Pharmaceuticals has significantly lagged behind with a 32.66% decline in the same period. This stark contrast highlights the challenges faced by Remus Pharmaceuticals in the current market environment, as it continues to struggle against both sector performance and broader market trends.